Editorial 1: Clinical Nanomedicine, a New Nano Domain

Heinrich Rohrer,

doi:10.1515/EJNM.2010.3.1.4

Startseite Editorial 1: Clinical Nanomedicine, a New Nano Domain

Artikel

Lizenziert

Nicht lizenziert Erfordert eine Authentifizierung

Editorial 1: Clinical Nanomedicine, a New Nano Domain

Heinrich Rohrer,

Veröffentlicht/Copyright: 1. Mai 2010

Veröffentlicht von

Veröffentlichen auch Sie bei De Gruyter Brill

Informationen für Autor*innen

Aus der Zeitschrift European Journal of Nanomedicine Band 3 Heft 1

MLA
APA
Harvard
Chicago
Vancouver

MLA
APA
Harvard
Chicago
Vancouver

Rohrer,, Heinrich. "Editorial 1: Clinical Nanomedicine, a New Nano Domain" European Journal of Nanomedicine, vol. 3, no. 1, 2010, pp. 4-4. https://doi.org/10.1515/EJNM.2010.3.1.4

Rohrer,, H. (2010). Editorial 1: Clinical Nanomedicine, a New Nano Domain. European Journal of Nanomedicine, 3(1), 4-4. https://doi.org/10.1515/EJNM.2010.3.1.4

Rohrer,, H. (2010) Editorial 1: Clinical Nanomedicine, a New Nano Domain. European Journal of Nanomedicine, Vol. 3 (Issue 1), pp. 4-4. https://doi.org/10.1515/EJNM.2010.3.1.4

Rohrer,, Heinrich. "Editorial 1: Clinical Nanomedicine, a New Nano Domain" European Journal of Nanomedicine 3, no. 1 (2010): 4-4. https://doi.org/10.1515/EJNM.2010.3.1.4

Rohrer, H. Editorial 1: Clinical Nanomedicine, a New Nano Domain. European Journal of Nanomedicine. 2010;3(1): 4-4. https://doi.org/10.1515/EJNM.2010.3.1.4

Kopie

In die Zwischenablage kopiert

BibTeX EndNote RIS

Published Online: 2010-05

Published in Print: 2010-05

Sie haben derzeit keinen Zugang zu diesem Inhalt.

Artikel in diesem Heft

Editorial 1: Clinical Nanomedicine, a New Nano Domain
Editorial 2: Editorial from the CEO
Editorial 3: Nanomedicine – shaping the future of medicine in a context of academia, industry and politics
Clinical Nanomedicine: Nanomedical approaches in Alzheimer’s disease
Nanophysiology: The Janus Face of Immune Stimulation by Nanomedicines: Examples for the Good and the Bad
Therapeutic Nanomedicine: Cross linked micelles with transiently linked drugs – a versatile drug delivery system
Preventive Nanomedicine: Nanomedicine for dendritic cell-targeted immunotherapy
Nanomethods: Scanning X-ray scattering: Evaluating the nanostructure of human tissues
Nanopharmaceuticals: Nanopharmaceuticals
The Landscape of Nanomedicine: Nanomedicine and Nanotoxicology at PHARMA–Copenhagen University

Zeitschrift durchsuchen In dieser Zeitschrift suchen

https://doi.org/10.1515/EJNM.2010.3.1.4

Artikel in diesem Heft

Editorial 1: Clinical Nanomedicine, a New Nano Domain
Editorial 2: Editorial from the CEO
Editorial 3: Nanomedicine – shaping the future of medicine in a context of academia, industry and politics
Clinical Nanomedicine: Nanomedical approaches in Alzheimer’s disease
Nanophysiology: The Janus Face of Immune Stimulation by Nanomedicines: Examples for the Good and the Bad
Therapeutic Nanomedicine: Cross linked micelles with transiently linked drugs – a versatile drug delivery system
Preventive Nanomedicine: Nanomedicine for dendritic cell-targeted immunotherapy
Nanomethods: Scanning X-ray scattering: Evaluating the nanostructure of human tissues
Nanopharmaceuticals: Nanopharmaceuticals
The Landscape of Nanomedicine: Nanomedicine and Nanotoxicology at PHARMA–Copenhagen University